MetLife Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-73,099
Closed -$101K 2791
2024
Q4
$101K Buy
+73,099
New +$101K ﹤0.01% 2621
2024
Q3
Sell
-62,706
Closed -$108K 2862
2024
Q2
$108K Buy
62,706
+8,552
+16% +$14.8K ﹤0.01% 2566
2024
Q1
$129K Buy
54,154
+1,024
+2% +$2.45K ﹤0.01% 2419
2023
Q4
$177K Hold
53,130
﹤0.01% 2301
2023
Q3
$199K Buy
53,130
+14,239
+37% +$53.3K ﹤0.01% 2213
2023
Q2
$166K Hold
38,891
﹤0.01% 2388
2023
Q1
$266K Hold
38,891
﹤0.01% 2051
2022
Q4
$308K Hold
38,891
﹤0.01% 1966
2022
Q3
$374K Buy
38,891
+4,003
+11% +$38.5K ﹤0.01% 1848
2022
Q2
$253K Hold
34,888
﹤0.01% 2148
2022
Q1
$450K Buy
34,888
+13,564
+64% +$175K ﹤0.01% 1839
2021
Q4
$340K Hold
21,324
﹤0.01% 1727
2021
Q3
$343K Hold
21,324
﹤0.01% 1753
2021
Q2
$295K Hold
21,324
﹤0.01% 1901
2021
Q1
$312K Sell
21,324
-7,082
-25% -$103K ﹤0.01% 1793
2020
Q4
$494K Hold
28,406
﹤0.01% 1505
2020
Q3
$521K Hold
28,406
0.01% 1349
2020
Q2
$507K Hold
28,406
0.01% 1369
2020
Q1
$461K Hold
28,406
0.01% 1261
2019
Q4
$511K Hold
28,406
0.01% 1451
2019
Q3
$576K Buy
28,406
+5,934
+26% +$120K 0.01% 1342
2019
Q2
$497K Hold
22,472
0.01% 1484
2019
Q1
$307K Hold
22,472
﹤0.01% 1742
2018
Q4
$203K Hold
22,472
﹤0.01% 1900
2018
Q3
$371K Buy
+22,472
New +$371K ﹤0.01% 1724